# 18 — How to Disprove the Oxalate–Psychiatry Hypothesis
Series: The Oxalate–Brain Hypothesis
Evidence class: Methodological paper; no positive effect assumed

## Abstract
A frontier hypothesis deserves publication when it creates discriminating predictions, not merely a convincing story. The oxalate–psychiatry hypothesis spans several non-equivalent claims: renal complications causing encephalopathy, rare cerebral oxalosis, and direct psychiatric effects from ordinary food intake. We propose a falsification framework that makes the last and most controversial claim vulnerable to negative evidence.

## Separate the causal graphs
Model A is the established renal route: increased oxalate burden leads to renal deposition and injury, which in severe cases contributes to systemic metabolic disturbance and altered cerebral function. Model B is a rare systemic-deposition route. Model C proposes a direct or partly independent neural effect at concentrations encountered in common diets. These models predict different exposure thresholds, biomarker patterns and clinical presentations. A study finding no direct effect cannot refute Model A, while observing kidney injury does not validate Model C.

## Design around competing causes
A good observational analysis would characterize habitual diet, 24-hour oxalate excretion where relevant, renal filtration, stone history, malabsorption, calcium intake, vitamin C use, medications, sleep, psychiatric history and objective outcomes. Samples should distinguish inherited hyperoxaluria, enteric hyperoxaluria and healthy controls. Because diet and mental health can influence one another, longitudinal measurements are preferable to single snapshots. Autistic participants require assessment of dietary selectivity and gastrointestinal comorbidity rather than assumptions about developmental causation.

## Strong disconfirming observations
Repeatedly normal oxalate biomarkers during psychiatric episodes would undermine the hypothesis of a circulating burden in those episodes. Lack of any association after adjusting for renal impairment, nutritional status and medication exposure would weaken broad claims. An intervention that reduces urinary oxalate without changing psychiatric outcomes would specifically undermine an oxalate-mediated symptom pathway, though not the intervention's value for stones. A clinically important psychiatric effect only in end-stage kidney disease would favor indirect systemic illness rather than a common dietary syndrome.

## Ethics and communication
Provocative research should not expose susceptible people to deliberate nephrotoxic oxalate challenges or deny psychiatric treatment while searching for a dietary cause. Publication must explicitly reject using oxalate theories to infer guilt, innocence or moral responsibility in specific tragedies. The Institute should present estimated plausibility in proportion to data, avoid unverified numerical predictions and correct its preferred theory if evidence fails.

## Publication standard and falsifiability ledger
Every strong claim should have a paired rival explanation. “High urinary oxalate correlates with anxiety” competes with changes in hydration, diet, kidney function, sleep, pain and selection bias. “A reduction diet improved behavior” competes with caloric normalization, medication adjustments, attention effects, regression to the mean and symptom fluctuation. “Oxalate causes autism” competes with reverse causality through dietary selectivity and other downstream physiological differences.

The hypothesis should be stratified into tiers. **Tier one:** established intestinal, metabolic and renal oxalate mechanisms. **Tier two:** neurological consequences of advanced systemic disease or kidney-mediated encephalopathy. **Tier three:** direct or independent psychiatric effects at everyday dietary exposure. A result supporting one tier cannot be quietly counted as evidence for the others. Publishing this ledger beside the theory makes the Institute's stance auditable: uncertainty is a feature of the work, not a defect to conceal.

## Conclusion
The oxalate–psychiatry hypothesis gains scientific value by agreeing in advance to circumstances under which it would be narrowed or abandoned. The present strongest propositions concern kidney disease and rare systemic oxalosis; common psychiatric causation remains an unanswered question, not a discovered fact.

## Selected readings
- Witting et al., Enteric Hyperoxaluria: https://pmc.ncbi.nlm.nih.gov/articles/PMC8011014/
- Konstantynowicz et al., Oxalate and autism association: https://pubmed.ncbi.nlm.nih.gov/21911305/
- Mulay et al., Oxalate and NLRP3: https://doi.org/10.1172/JCI63679